Espironolactona e eplerenona são cardioprotetoras durante a fase precoce de isquemia em ratos submetidos à oclusão coronária

Autor: Gabriela de Cássia Sousa Amancio, Milla Marques Hermidorff, Ana Cláudia Alvarenga, Wanderson Geraldo Lima, Homero Nogueira Guimarães, Henrique Resende Rodrigues, Emília Calil Silva, Leonardo Vinícius Monteiro de Assis, Andrea Grabe-Guimarães, Mauro Cesar Isoldi

Publikováno v: Research, Society and Development; Vol. 11 No. 3; e24011326498
Research, Society and Development; Vol. 11 Núm. 3; e24011326498
Research, Society and Development; v. 11 n. 3; e24011326498
Research, Society and Development
Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI

Introduction: Mineralocorticoid receptor antagonists (MRAs) are effective in reducing left ventricle remodeling and sudden death after acute myocardial infarction (AMI). Objectives: MRAs in vitro display cardioprotective effects, independent of MR; h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ad1deb89cfd20f414fc2b47caba3710
https://doi.org/10.33448/rsd-v11i3.26498